Salamaña, Mard Q.

HRN: 22-17-92  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/09/2022
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
11/09/2022
11/15/2022
IVT
1.5g
Q6h
Sepsis, Uti; Intraabdominal,
Waiting Final Action 
11/23/2022
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
11/23/2022
11/30/2022
IV INFUSION
4.5g
Q6
Increasing WBC Trend; Staghorn Calculi, Recurring UTI
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: